Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trinity Biotech (TRIB) Profit After Tax (2016 - 2024)

Trinity Biotech's Profit After Tax history spans 16 years, with the latest figure at -$17.0 million for Q4 2024.

  • On a quarterly basis, Profit After Tax fell 208.16% to -$17.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$31.8 million, a 7370.19% decrease, with the full-year FY2025 number at -$2.3 million, up 92.65% from a year prior.
  • Profit After Tax hit -$17.0 million in Q4 2024 for Trinity Biotech, down from -$4.8 million in the prior quarter.
  • Over the last five years, Profit After Tax for TRIB hit a ceiling of $11.8 million in Q2 2023 and a floor of -$17.0 million in Q4 2024.
  • Historically, Profit After Tax has averaged -$3.8 million across 5 years, with a median of -$3.5 million in 2020.
  • Biggest five-year swings in Profit After Tax: skyrocketed 297.7% in 2021 and later crashed 2026.0% in 2022.
  • Tracing TRIB's Profit After Tax over 5 years: stood at -$10.0 million in 2020, then soared by 87.38% to -$1.3 million in 2021, then tumbled by 696.84% to -$10.1 million in 2022, then soared by 45.42% to -$5.5 million in 2023, then tumbled by 208.16% to -$17.0 million in 2024.
  • Business Quant data shows Profit After Tax for TRIB at -$17.0 million in Q4 2024, -$4.8 million in Q3 2024, and -$10.1 million in Q2 2024.